Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) Return on Sales (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Return on Sales for 2 consecutive years, with 246.75% as the latest value for Q4 2024.

  • On a quarterly basis, Return on Sales fell 24036.0% to 246.75% in Q4 2024 year-over-year; TTM through Dec 2024 was 246.75%, a N/A change, with the full-year FY2024 number at 260.45%, down 25958.0% from a year prior.
  • Return on Sales was 246.75% for Q4 2024 at Artiva Biotherapeutics, down from 28.16% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1.42% in Q2 2024 to a low of 246.75% in Q4 2024.